ATOME Energy should more than double its underlying earnings, improve returns, and receive a faster payback after shifting its Villeta project in Paraguay from green hydrogen into green fertiliser production, according to analysts at finnCap.
“Refocusing Villeta into fertilisers widens the spectrum of potential funding institutions, capturing the food and agriculture sectors as well as energy and infrastructure,” the analysts said.
Coinsilium Group Ltd (AQSE:COIN, OTCQB:CINGF) said its stake in portfolio company Greengage Global is now valued at over £0.6mln after the conversion of a loan note and a contribution to its latest funding round, up over 25% on its original investment.
UK-based Greengage raised a total of £1mln in the first tranche of its £5mln fundraise, at a valuation of £30mln or £24.05 per share.
Eco Buildings Group PLC (AIM:ECOB) is on course to have its Albanian factory fully operational by the third quarter, allowing it to deliver modular housing contracts worth €114mln.
The 3,000-square metre facility is near the modern commercial port of Durres and was relocated from Dubai.
JLEN Environmental Assets- Group Ltd (LSE:JLEN) said its net asset value (NAV) rose by almost 7% as the trust upped its forecast for electricity prices in the future.
The battery storage specialist has contracts linked to inflation and these plus higher power prices added 18.9p to the trust's NAV of 123.1p as at the end of March 2023.
NetScientific has welcomed new data from portfolio company PDS Biotechnology showing more patients saw a measurable benefit in the ongoing VERSATILE-002 head and neck cancer trial.
Fourteen patients in the immune checkpoint inhibitor naïve arm of VERSATILE-002 experienced either a complete response or partial response on two consecutive scans, thus constituting a confirmed objective response, PDS noted.
Iofina PLC (AIM:IOF, OTC:IOFNF) has announced today that its IO#9 IOsorb plant is now operational and, following hydrotesting, the plant has commenced the flow of brine water.
Situated in a new core area with substantial oil and gas drilling activity, IO#9 represents the company's sixth plant in Oklahoma, developed in collaboration with a new partner. Iofina anticipates a swift return on investment as the production from IO#9 is expected to significantly enhance the group's overall output. The rates are projected to increase by 100-150MT (million tonnes) of crystalline iodine annually.
Mila Resources PLC said drilling will restart at its Kathleen Valley gold project in Western Australia next week with a "small and targeted" programme while talks with a potential farm-in partner are advancing.
Six holes will be drilled with a reverse circulation (RC) rig, with depths from 90-180 metres (m), building on last year's drilling.
MP Evans Group PLC (AIM:MPE), a producer of sustainable Indonesian palm oil, said it intends to commence a £2mln share buyback programme.
All shares bought under the programme, which starts today, will be cancelled, according to a statement.
Quadrise PLC (AIM:QED)’s licence and supply agreement with Valkor has “delighted” analysts at Shore Capital.
“We continue to see huge potential for bioMSAR and MSAR (lower carbon fuels) for marine and industrial usage,” the broker said.
Atlantic Lithium Limited (AIM:ALL, OTCQX:ALLIF, ASX:A11) is looking for a new board member after the group confirmed Stuart Crow, a senior non-executive director, would be stepping down with immediate effect.
Having had a seat on the board for ten years, the corporate finance and investor relations expert is leaving to focus on his other business interests.
Genflow Biosciences PLC (LSE:GENF), the anti-ageing company, has announced a new milestone: its shares begin trading today, Tuesday 13 June, on the OTCQB Venture Market in the United States, under the ticker symbol GENFF.
This comes in addition to its current listing on the London Stock Exchange's Main Market. Importantly, this development will not entail any additional capital raise.
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has achieved significant results in laboratory studies involving its anti-cancer mRNA treatment.
In straightforward terms, mRNA treatments instruct cells on how to fight diseases such as cancer. These studies have shown a marked decrease in both the growth and spread of breast and liver cancer cells.
Liberum has updated its target price for Futura Medical PLC (AIM:FUM, OTC:FAMDF) shares from 121p to 142p after the latter's announcement of US Food & Drug Administration approval for MED3000, a treatment for erectile dysfunction (ED), according to the corporate broker's research note.
This development marks a significant milestone for Futura, further strengthening the investment case in the Liberum's view.
Quadrise PLC (AIM:QED) has signed a site licence and supply agreement with Valkor Technologies LLC to produce and sell its carbon-reducing technology at the latter’s Utah heavy oil asset.
Quadrise’s MSAR and bioMSAR fuels will be produced and sold from Valkor’s site as part of a US$1.5mln deal, which could produce revenues for the former from August this year.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) said Darryll Castle has joined its board as a non-executive director through the nomination right held by TechMet Limited.
TechMet can nominate one director to the board for so long as it holds at least 10% of the shares, with its stake now at 12.0% following its recent participation in a placing.
In a significant milestone for UK-based Futura Medical PLC (AIM:FUM, OTC:FAMDF) and a first for the US, the Food and Drug Administration (FDA) has approved the over-the-counter marketing of the company's innovative topical gel for erectile dysfunction (ED).
MED3000 can now be sold without prescription, paving the way for the topical ED treatment to become available on the shelves of American pharmacies.